Chardan Capital Markets Downgrades Adverum Biotechnologies (ADVM) to Neutral Oct 27, 2025 03:53AM
Adverum Biotechnologies to Participate in Upcoming Fall Investor Conferences Sep 4, 2024 04:05PM
Adverum Biotechnologies to Participate in Upcoming Investor Conferences Sep 21, 2023 04:05PM
Adverum Biotechnologies to Participate in the Chardan 6th Annual Genetic Medicines Conference Sep 27, 2022 04:05PM
Chardan Capital Markets Downgrades Adverum Biotechnologies (ADVM) to Neutral Apr 29, 2021 10:05AM


Mar 17, 2021 05:10PM Adverum Announces Board Slate for 2021 Annual Meeting and Reiterates Commitment to Stockholder Value Creation
Feb 10, 2020 09:55AM UPDATE: Chardan Capital Markets Upgrades Adverum Biotechnologies (ADVM) to Buy
Mar 18, 2019 09:00AM Adverum Biotechnologies to Participate in Upcoming Conferences
Nov 2, 2018 09:05AM Adverum Biotechnologies (ADVM) PT Lowered to $4.50 at Chardan Capital Markets
Sep 28, 2017 09:00AM Adverum Biotechnologies to Present at Upcoming Conferences
Jun 8, 2016 07:50AM UPDATE: Chardan Capital Markets Downgrades Adverum Biotechnologies (ADVM) to Neutral